TrialArthritis research & therapy2019

Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet's disease: a large-scale, long-term postmarketing surveillance in Japan.

Shigeaki Ohno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.